INHALER DEVICE IDENTIFICATION asthmafoundation.org.

nz

RELIEVERS
Short-Acting Beta2 Agonists (SABA) Short-Acting Muscarinic Antagonists (SAMA) Combination SABA + SAMA
SALBUTAMOL TERBUTALINE IPRATROPIUM SALBUTAMOL + IPRATROPIUM
Respigen ®
SalAir ®
Ventolin ®
Bricanyl ®
Atrovent ®
Duolin HFA®

$ $ $ $ $ $

100 mcg 250 mcg 20 mcg 100 mcg/20 mcg

Aerosol inhaler Turbuhaler® Aerosol inhaler Aerosol inhaler

Inhaled Corticosteroids (ICS)

PREVENTERS
FLUTICASONE propionate BUDESONIDE BECLOMETHASONE dipropionate
Flixotide®
Pulmicort ®
Beclazone® Qvar® (ultrafine particle)

$ $ $ $
$ $ $
$ $ $ $
$ $ $

50 mcg 125 mcg 250 mcg 50 mcg 100 mcg 250 mcg 100 mcg 200 mcg 400 mcg 50 mcg 100 mcg 250 mcg 50 mcg 100 mcg
Aerosol inhaler Accuhaler® Turbuhaler® Note: Beclazone and Qvar are not dose equivalent and are not interchangeable
® ®

RELIEVER+PREVENTER
Combination Inhaled Corticosteroids (ICS) + Long-Acting Beta2 Agonists (LABA)
FLUTICASONE propionate + SALMETEROL FLUTICASONE furoate BUDESONIDE + FORMOTEROL
Seretide® + VILANTEROL Vannair ®
Symbicort® DuoResp Spiromax®
Breo Ellipta®
$ $
$ $ $ $ $ $ $ $ $ $ $

50/25 125/25 250/25 100/50* 250/50* 100/6 200/6 100/6 200/6 400/12* 200/6 400/12*
Aerosol inhaler Accuhaler® 100 mcg/25 mcg Aerosol inhaler Turbuhaler® Dry powder inhaler
*100/50 and 250/50 accuhaler only funded Dry powder inhaler *Symbicort 400/12 and DuoResp Spiromax 400/12 only funded if no more than 2 doses per day
if no more than 2 doses per day Note: 200 mcg/25 mcg strength Note: Symbicort 100/6, 200/6 and DuoResp Spiromax 200/6 are currently approved for Anti-Inflammatory Reliever (AIR)
available but not funded therapy. Vannair 100/6 and 200/6 is approved for maintenance use, but its use in AIR therapy is an unapproved indication.

Funding information updated as of 1 September 2022. D O W N L O A D AT:

$ Funded $ Not funded $ Partially funded Visit www.pharmac.govt.nz nzrespiratoryguidelines.co.nz
 INHALER DEVICE IDENTIFICATION asthmafoundation.org.nz

LONG-ACTING SYMPTOM CONTROLLERS (FOR COPD)

Long-Acting Beta2 Agonists (LABA)

SALMETEROL FORMOTEROL (eformoterol) INDACATEROL

Serevent ®
Oxis ®
Foradil ®
Onbrez Breezhaler®
$ $ $
$ $

25 mcg 50 mcg 6 mcg 12 mcg 150 mcg 300 mcg

Aerosol inhaler Accuhaler® Turbuhaler® Aerolizer device® Breezhaler®

Long-Acting Muscarinic Antagonists (LAMA) Combination Long-Acting Muscarinic Antagonists (LAMA)

+ Long-Acting Beta2 Agonists (LABA)
TIOTROPIUM UMECLIDINIUM GLYCOPYRRONIUM
Spiriva ®
Spiriva Incruse Seebri® TIOTROPIUM UMECLIDINIUM GLYCOPYRRONIUM
Respimat® Ellipta® Breezhaler® + OLODATEROL + VILANTEROL + INDACATEROL
Spiolto Anoro Ultibro®
$ $ $ $ Respimat® Ellipta® Breezhaler®

$ $ $
18 mcg 2.5 mcg 62.5 mcg 50 mcg
Handihaler® Fine mist inhaler Dry powder inhaler Breezhaler®

Funded by Endorsement: LAMA inhaler is subsidised only for patients who have been 2.5 mcg/2.5 mcg 62.5 mcg/25 mcg 50 mcg/110 mcg
diagnosed as having COPD using spirometry if spirometry is possible, and the prescription Fine mist inhaler Dry powder inhaler Breezhaler®
is endorsed accordingly (i.e. COPD documented as indication on prescription).
Not subsidised if patient is also receiving treatment with another subsidised LAMA. Funded via Special Authority: LAMA + LABA inhaler is subsidised only for patients who have been
stabilised on a LAMA and the prescriber considers that the patient would receive additional benefit
from switching to a combination product. Not subsidised if patient is also receiving treatment with a
combination ICS and LABA.

$ Funded $ Not funded $ Partially funded Spacers are available free to those who need them on a Practitioners Supply Order (PSO).
Contact Manatū Hauora Ministry of Health for an order form on 0800 353 2425.
$ Funded by endorsement $ Funded by Special Authority Everyone should have an action plan. Find a range of management plans at asthmafoundation.org.nz

ARFNZ would like to acknowledge the Clinical Pharmacy Department, Counties Manukau Health, for the source template.